Abstract

30
To investigate the effects of subcutaneous detemir on glucose flux, lipid metabolism and 31 brain function, twelve people with type 1 diabetes received in random order 0.5Units/kgBW 32 detemir or NPH insulin. Glucose concentration was clamped at 5mmol/L then increased to 33 10mmol/L. Glucose production rate (glucose Ra), glucose uptake (glucose Rd) and glycerol 34 production (glycerol Ra) were measured with a constant iv infusion of [ Interpretation during hyperglycaemia is difficult as the differences may result from increased 159 rate of peripheral glucose uptake in the NPH group rather than a direct difference of insulin 160 action in the brain. There were also differences in AC-potentials, with activation of theta and 161 alpha activity in frontocentral cerebrocortical regions. The exact significance remains unclear.
162
Although, we cannot determine the underlying molecular mechanism, the greater action of 163 detemir in the brain may be related to its albumin binding or the novel method of protraction.
164
The capillary endothelial barrier in peripheral tissue may limit the transfer of detemir from the 165 circulation into the extravascular space. Detemir may also cross the blood brain barrier (BBB) 166 more easily than human insulin (9), perhaps due detemir's lipophilic property (10). 
